Knockdown of let-7b in LAMs was shown to suppress AML progression by reprogramming LAMs toward an M1-like phenotype, mediated through the activation of the Toll-like receptor and NF-κB signaling pathways (156). The gene discussed is NFKB1; the disease is acute myeloid leukemia.